LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.23%451.93M | 9.07%437.51M | 10.68%499.88M | 23.16%1.69B | 17.27%434.6M | 21.59%406.3M | 26.57%401.14M | 27.75%451.64M | 30.29%1.38B | 30.04%370.61M |
Operating revenue | 11.23%451.93M | 9.07%437.51M | 10.68%499.88M | 23.16%1.69B | 17.27%434.6M | 21.59%406.3M | 26.57%401.14M | 27.75%451.64M | 30.29%1.38B | 30.04%370.61M |
Cost of revenue | 28.16%88.35M | 24.41%83.88M | 20.54%78.63M | 29.87%276.29M | 26.44%74.69M | 25.11%68.94M | 34.64%67.43M | 34.54%65.23M | 31.41%212.74M | 26.97%59.07M |
Gross profit | 7.77%363.58M | 5.97%353.63M | 9.02%421.25M | 21.93%1.42B | 15.53%359.91M | 20.89%337.36M | 25.06%333.71M | 26.68%386.41M | 30.08%1.16B | 30.64%311.54M |
Operating expense | 7.59%258.71M | 4.89%258.49M | -40.07%135.44M | 23.25%966.06M | 23.08%253.18M | 17.41%240.46M | 26.69%246.45M | 26.41%225.97M | 22.45%783.8M | 21.12%205.7M |
Selling and administrative expenses | 1.23%175.12M | -3.00%176.94M | -60.15%67.42M | 20.50%705.75M | 18.62%181.19M | 13.95%172.99M | 25.24%182.4M | 24.86%169.18M | 20.55%585.69M | 22.09%152.75M |
-Selling and marketing expense | 3.28%104.48M | 0.40%106.86M | 11.54%115.52M | 20.50%417.62M | 14.80%106.45M | 11.03%101.16M | 21.33%106.44M | 38.11%103.57M | 25.57%346.56M | 22.80%92.73M |
-General and administrative expense | -1.65%70.64M | -7.76%70.07M | -173.32%-48.1M | 20.49%288.14M | 24.52%74.74M | 18.34%71.83M | 31.17%75.97M | 8.43%65.61M | 13.96%239.13M | 21.00%60.02M |
Research and development costs | 21.56%63.05M | 26.98%62.37M | 18.37%50.51M | 34.12%198.95M | 39.76%55.3M | 28.48%51.86M | 33.46%49.12M | 35.01%42.67M | 25.26%148.34M | 14.98%39.57M |
Depreciation amortization depletion | 31.61%20.54M | 28.50%19.18M | 23.94%17.51M | 23.30%61.36M | 24.73%16.7M | 23.63%15.61M | 23.47%14.93M | 21.11%14.13M | 38.96%49.76M | 29.86%13.39M |
-Depreciation and amortization | 31.61%20.54M | 28.50%19.18M | 23.94%17.51M | 23.30%61.36M | 24.73%16.7M | 23.63%15.61M | 23.47%14.93M | 21.11%14.13M | 38.96%49.76M | 29.86%13.39M |
Operating profit | 8.23%104.87M | 9.02%95.14M | 78.15%285.81M | 19.18%451.32M | 0.84%106.72M | 30.48%96.9M | 20.68%87.27M | 27.06%160.43M | 49.34%378.68M | 54.22%105.83M |
Net non-operating interest income expense | -255.41%-789K | -29.90%-782K | 6.57%-782K | 24.01%-1.93M | 71.97%-266K | 78.19%-222K | -70.06%-602K | -289.30%-837K | -2.54M | -949K |
Non-operating interest expense | 255.41%789K | 29.90%782K | -6.57%782K | -24.01%1.93M | -71.97%266K | -78.19%222K | 70.06%602K | 289.30%837K | --2.54M | --949K |
Other net income (expense) | -21.13%4.23M | -22.58%4.79M | -16.57%5.01M | 71.22%23M | -40.08%5.46M | 162.71%5.36M | 604.21%6.18M | 325.21%6M | 460.96%13.44M | 561.63%9.1M |
Other non- operating income (expenses) | -21.13%4.23M | -22.58%4.79M | -16.57%5.01M | 71.22%23M | -40.08%5.46M | 162.71%5.36M | 604.21%6.18M | 325.21%6M | 460.96%13.44M | 561.63%9.1M |
Income before tax | 6.15%108.31M | 6.78%99.15M | 75.15%290.04M | 21.26%472.4M | -1.82%111.91M | 35.53%102.04M | 27.47%92.85M | 29.92%165.6M | 52.20%389.58M | 62.84%113.99M |
Income tax | 30.62%35.04M | 10.04%31.18M | -7.45%42.85M | 21.65%131.61M | -11.41%30.16M | 15.94%26.82M | 82.99%28.33M | 30.31%46.3M | 80.31%108.19M | 59.69%34.04M |
Net income | -2.58%73.28M | 5.35%67.97M | 107.20%247.19M | 21.11%340.79M | 2.26%81.76M | 44.23%75.22M | 12.49%64.52M | 29.77%119.3M | 43.60%281.39M | 64.21%79.95M |
Net income continuous Operations | -2.58%73.28M | 5.35%67.97M | 107.20%247.19M | 21.11%340.79M | 2.26%81.76M | 44.23%75.22M | 12.49%64.52M | 29.77%119.3M | 43.60%281.39M | 64.21%79.95M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -2.58%73.28M | 5.35%67.97M | 107.20%247.19M | 21.11%340.79M | 2.26%81.76M | 44.23%75.22M | 12.49%64.52M | 29.77%119.3M | 43.60%281.39M | 64.21%79.95M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -2.58%73.28M | 5.35%67.97M | 107.20%247.19M | 21.11%340.79M | 2.26%81.76M | 44.23%75.22M | 12.49%64.52M | 29.77%119.3M | 43.60%281.39M | 64.21%79.95M |
Basic earnings per share | 0.77%1.31 | 8.11%1.2 | 112.14%4.37 | 21.60%5.91 | 3.62%1.43 | 44.44%1.3 | 12.12%1.11 | 30.38%2.06 | 43.36%4.86 | 64.29%1.38 |
Diluted earnings per share | 0.77%1.31 | 8.11%1.2 | 112.14%4.37 | 21.49%5.88 | 3.62%1.43 | 44.44%1.3 | 12.12%1.11 | 30.38%2.06 | 43.62%4.84 | 64.29%1.38 |
Dividend per share | 0.00%0.375 | 0.00%0.375 | 0.375 | 1.125 | 0.375 | 0.375 | 0.375 | |||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |